第 1 到 20 筆結果,共 20 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2019 | Erratum: A novel peptide specifically binding to interleukin-6 receptor (gp80) inhibits angiogenesis and tumor growth (Cancer Research (2005) 65 (4827–4835) DOI: 10.1158/0008-5472.CAN-05-0188) | Su J.-L.; Lai K.-P; CHI-AN CHEN ; CHING-YAO YANG ; Chen P.-S; Chang C.-C; Chou C.-H; Hu C.-L; Kuo M.-L; CHANG-YAO HSIEH ; LING-HUNG WEI | Cancer Research | 1 | 1 | |
2 | 2015 | Standardized uptake value and apparent diffusion coefficient of endometrial cancer evaluated with integrated whole-body PET/MR: Correlation with pathological prognostic factors | I-LUN SHIH ; RUOH-FANG YEN ; CHI-AN CHEN ; BANG-BIN CHEN ; Wei S.-Y.; WEN-CHUN CHANG ; BOR-CHING SHEU ; WEN-FANG CHENG ; YAO-HUI TSENG ; Chen X.-J.; CHI-HAU CHEN ; LING-HUNG WEI ; YING-CHENG CHIANG ; PAO-LING TORNG ; MEN-LUH YEN ; TIFFANY TING-FANG SHIH | Journal of Magnetic Resonance Imaging | 44 | 38 | |
3 | 2015 | The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer | Hsiao S.-M; Chen M.-W; CHI-AN CHEN ; Chien M.-H; KUO-TAI HUA ; Hsiao M; Kuo M.-L; LING-HUNG WEI | Annals of Surgical Oncology | 31 | 28 | |
4 | 2014 | Arsenic Trioxide Inhibits CXCR4-Mediated Metastasis by Interfering miR-520h/PP2A/NF-κB Signaling in Cervical Cancer | Chang Y.-W; Chen M.-W; Chiu C.-F; Hong C.-C; Cheng C.-C; Hsiao M; CHI-AN CHEN ; LING-HUNG WEI ; Su J.-L. | Annals of Surgical Oncology | 26 | 24 | |
5 | 2011 | Histone Deacetylase 6 Regulates Estrogen Receptor α in Uterine Leiomyoma | LING-HUNG WEI ; PAO-LING TORNG ; Hsiao S.-M; YUNG-MING JENG ; Chen M.-W; CHI-AN CHEN | Reproductive Sciences | 23 | 22 | |
6 | 2011 | IL-6 trans-signaling in formation and progression of malignant ascites in ovarian cancer | Lo C.-W; Chen M.-W; Hsiao M; Wang S; CHI-AN CHEN ; Hsiao S.-M; Chang J.-S; Lai T.-C; Rose-John S; Kuo M.-L; LING-HUNG WEI | Cancer Research | 154 | 129 | |
7 | 2009 | Phase II trial of carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox®) in recurrent platinum-sensitive ovarian cancer following front-line therapy with paclitaxel and platinum | Hsiao S.-M; CHI-AN CHEN ; HO-HSIUNG LIN ; CHANG-YAO HSIEH ; LING-HUNG WEI | Gynecologic Oncology | 17 | 16 | |
8 | 2008 | Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma | Hsiao S.-M.; CHI-AN CHEN ; CHIUN HSU ; HO-HSIUNG LIN ; CHANG-YAO HSIEH ; LING-HUNG WEI | Anticancer Research | 2 | 1 | |
9 | 2006 | Pegylated liposomal doxorubicin (Lipo-Dox®) for platinum-resistant or refractory epithelial ovarian carcinoma: A Taiwanese gynecologic oncology group study with long-term follow-up | Chou H.-H; Wang K.-L; CHI-AN CHEN ; LING-HUNG WEI ; Lai C.-H; CHANG-YAO HSIEH ; Yang Y.-C; Twu N.-F; Chang T.-C; Yen M.-S. | Gynecologic Oncology | 70 | 64 | |
10 | 2005 | A novel peptide specifically binding to interleukin-6 receptor (gp80) inhibits angiogenesis and tumor growth | Su J.-L; Lai K.-P; CHI-AN CHEN ; CHING-YAO YANG ; Chen P.-S; Chang C.-C; Chou C.-H; Hu C.-L; Kuo M.-L; CHANG-YAO HSIEH ; LING-HUNG WEI | Cancer Research | 84 | 77 | |
11 | 2005 | Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-κB pathway by lysophosphatidic acid, an ovarian cancer-activating factor | Chou C.-H; LING-HUNG WEI ; Kuo M.-L; RUBY YUN-JU HUANG ; Lai K.-P; CHI-AN CHEN ; CHANG-YAO HSIEH | Carcinogenesis | 78 | 74 | |
12 | 2005 | Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor κB | LING-HUNG WEI ; Lai K.-P.; CHI-AN CHEN ; CHIA-HSIEN CHENG ; RUBY YUN-JU HUANG ; Chou C.-H.; Kuo M.-L.; CHANG-YAO HSIEH | Oncogene | 62 | 58 | |
13 | 2004 | Overexpression of Her-2/neu in Epithelial Ovarian Carcinoma Induces Vascular Endothelial Growth Factor C by Activating NF-κB: Implications for Malignant Ascites Formation and Tumor Lymphangiogenesis | CHANG-YAO HSIEH ; CHI-AN CHEN ; Chou C.-H; Lai K.-P; YUNG-MING JENG ; Kuo M.-L; LING-HUNG WEI | Journal of Biomedical Science | 38 | 33 | |
14 | 2003 | Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway | LING-HUNG WEI ; Kuo M.-L; CHI-AN CHEN ; Chou C.-H; Lai K.-B; CHIEN-NAN LEE ; CHANG-YAO HSIEH | Oncogene | 454 | 418 | |
15 | 2002 | Radical hysterectomy alone or combined with neoadjuvant chemotherapy in the treatment of early stage bulky cervical carcinoma | CHI-AN CHEN ; WEN-FANG CHENG ; LING-HUNG WEI ; Su Y.-N.; CHANG-YAO HSIEH | Journal of the Formosan Medical Association | 19 | ||
16 | 2001 | Cytosol vascular endothelial growth factor in endometrial carcinoma: Correlation with disease-free survival | CHI-AN CHEN ; WEN-FANG CHENG ; CHIEN-NAN LEE ; LING-HUNG WEI ; Chu J.-S.; FON-JOU HSIEH ; CHANG-YAO HSIEH | Gynecologic Oncology | 33 | 28 | |
17 | 2001 | The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway | LING-HUNG WEI ; Kuo M.-L.; CHI-AN CHEN ; Chou C.-H.; WEN-FANG CHENG ; Chang M.-C.; Su J.-L.; CHANG-YAO HSIEH | Oncogene | 156 | 145 | |
18 | 2001 | Interleukin-6 in cervical cancer: The relationship with vascular endothelial growth factor | LING-HUNG WEI ; Kuo M.-L; CHI-AN CHEN ; WEN-FANG CHENG ; Cheng S.-P; FON-JOU HSIEH ; CHANG-YAO HSIEH | Gynecologic Oncology | 98 | 92 | |
19 | 2001 | Carcinosarcoma of ovary associated with previous radiotherapy | LING-HUNG WEI ; Huang C.-Y.; Cheng S.-P.; CHI-AN CHEN ; CHANG-YAO HSIEH | International Journal of Gynecological Cancer | 14 | 12 | |
20 | 2000 | Vascular endothelial growth factor and prognosis of cervical carcinoma | WEN-FANG CHENG ; CHI-AN CHEN ; CHIEN-NAN LEE ; LING-HUNG WEI ; FON-JOU HSIEH ; CHANG-YAO HSIEH | Obstetrics and Gynecology | 0 |